PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6708027

Postpartum depression.

M J Garvey·G D Tollefson
View original source ↗Export metadata ↓

Abstract

Postpartum depression (PPD) occurs in 4% of women during the puerperium. Patients with a previous history of depression, especially a postpartum depression, have a much greater incidence of PPD. Those patients should be evaluated carefully during the six-week period following parturition. PPD is to be differentiated from "baby blues," which occur in more than 50% of women postpartum. Baby blues are characterized by intermittent, mild affective symptoms that remit spontaneously after several days.

Explore related subjects

Antidepressive AgentsDepressionFemaleHormonesHumansPostnatal CarePregnancyPuerperal DisordersJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M J Garvey, G D Tollefson. 1984. Postpartum depression.. https://pubmed.ncbi.nlm.nih.gov/6708027/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Panic disorder.

Panic disorder is a chronic illness that affects at least 3 percent of the population. Panic disorder is associated with significant morbidity and an increased risk of suicide. Patients generally present with multiple somatic and psychologic complaints, including heart palpitations, chest pain, tremor, shortness of breath, choking, nausea or abdominal distress, dizziness, derealization, fear of losing control or going crazy, fear of dying, paresthesias, chills or hot flushes, headache, diarrhea, insomnia, chronic fatigue, anxiety and depression. To make the correct diagnosis, these symptoms must be evaluated carefully since they also occur with serious cardiovascular, pulmonary, endocrinologic and neurologic disorders. Many effective treatments are available, including tricyclic antidepressants, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, benzodiazepines such as alprazolam and clonazepam, and psychotherapy.

Antidepressive Agents↗